CUSTOM I

Our CUSTOM I clinical trial was designed to evaluate the preliminary safety and efficacy of in situ customization using the XTENT^® Custom NX^® 36 DES System. Enrollment of 30 patients was completed in July 2005 at three cardiology centers in Europe, with patient follow up at 30 days, four months, eight months, and annually for 5 years.